For example, doxorubicin, paclitaxel, or albumin-paclitaxel (Abraxane) has shown interesting effects in pre-clinical models of glioblastoma [30,47,48], but the lack of BBB passage impedes reaching a sufficient therapeutic concentration at the tumor site [49,50]. The gene discussed is ALB; the disease is neoplasm.